2007
DOI: 10.1016/j.yexcr.2006.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Critical involvement of ILK in TGFβ1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
25
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(26 citation statements)
references
References 64 publications
1
25
0
Order By: Relevance
“…TGFb1 secretion was impaired in mesangial cells transfected with a kinase-dead mutant of ILK (Ortega-Velazquez et al, 2004). Inhibition of ILK by knockdown (Lin et al, 2007) or by small molecule inhibitors (Edwards et al, 2008) also resulted in selected suppression of secreted vascular endothelial growth factor and urokinase plasminogen activator levels, but not those of PAI-1, indicating that ILK is involved in specific intracellular protein processing events and/or secretory pathways. Alternatively, proteolytic mobilization of latent TGFb1 from extracellular growth factor deposits, on the cell surface or in the ECM, might be impaired, leading to reduced levels of TGFb1 precursor available to the cells for activation.…”
Section: Ilk-deficient Fibroblasts In Mouse Skin Repairmentioning
confidence: 99%
“…TGFb1 secretion was impaired in mesangial cells transfected with a kinase-dead mutant of ILK (Ortega-Velazquez et al, 2004). Inhibition of ILK by knockdown (Lin et al, 2007) or by small molecule inhibitors (Edwards et al, 2008) also resulted in selected suppression of secreted vascular endothelial growth factor and urokinase plasminogen activator levels, but not those of PAI-1, indicating that ILK is involved in specific intracellular protein processing events and/or secretory pathways. Alternatively, proteolytic mobilization of latent TGFb1 from extracellular growth factor deposits, on the cell surface or in the ECM, might be impaired, leading to reduced levels of TGFb1 precursor available to the cells for activation.…”
Section: Ilk-deficient Fibroblasts In Mouse Skin Repairmentioning
confidence: 99%
“…Importantly, siRNA-mediated depletion of ILK impairs the phosphorylation of Akt at Ser473 in several cancer-cell models (Basaki et al, 2007;Duxbury et al, 2005;Edwards et al, 2006;Liu et al, 2006;McDonald et al, 2008;Tan et al, 2004), which results in the induction of apoptosis (Duxbury et al, 2005;McDonald et al, 2008;Shi et al, 2007). In addition, knockdown of ILK impaired the migration and invasion of cancer cells Shi et al, 2007;Wong et al, 2007) under standard growth conditions and subsequent to agonist stimulation (Lin et al, 2007;Shi et al, 2007). Reduced stress-fiber formation and defects in adhesion and spreading were seen in ILK-depleted melanoma cells, and this might underlie some of the observed migration and invasion defects (Wong et al, 2007).…”
Section: Genetic Inhibition Of Ilk Function In Cancer Cellsmentioning
confidence: 99%
“…RNAi and antisense oligonucleotides have been used in the cell culture setting to show that depletion of ILK expression leads to the reversal of many of its oncogenic effects, including a decrease in cell migration and invasion [88,91,150] and the induction of apoptosis [87][88][89][90][91]. In vivo, tumour xenografts derived from ILK-depleted cells show slower growth than controls [90,91].…”
Section: Ilk As a Potential Target For Cancer Therapeuticsmentioning
confidence: 99%